LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 303 of 535
Next
>>
>
7551 to 7575 of 13356 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	Palbociclib	0.37	uM	LJP6	3	E16	72	hr	1097	1655	3696	0.4477	0.2643
BT-20	Palbociclib	1.11	uM	LJP6	1	E15	72	hr	1097	1529	3610	0.4235	0.2130
BT-20	Palbociclib	1.11	uM	LJP6	2	E15	72	hr	1097	1579	3713	0.4252	0.2299
BT-20	Palbociclib	1.11	uM	LJP6	3	E15	72	hr	1097	1518	3696	0.4107	0.2035
BT-20	Palbociclib	3.33	uM	LJP6	1	E14	72	hr	1097	1530	3610	0.4238	0.2135
BT-20	Palbociclib	3.33	uM	LJP6	2	E14	72	hr	1097	1595	3713	0.4295	0.2370
BT-20	Palbociclib	3.33	uM	LJP6	3	E14	72	hr	1097	1576	3696	0.4264	0.2295
BT-20	Palbociclib	10	uM	LJP6	1	E13	72	hr	1097	1610	3610	0.4459	0.2500
BT-20	Palbociclib	10	uM	LJP6	2	E13	72	hr	1097	1540	3713	0.4147	0.2125
BT-20	Palbociclib	10	uM	LJP6	3	E13	72	hr	1097	1410	3696	0.3815	0.1539
BT-20	PF562271	0.04	uM	LJP6	1	F18	72	hr	1097	3248	3610	0.8996	0.8805
BT-20	PF562271	0.04	uM	LJP6	2	F18	72	hr	1097	3782	3713	1.0184	1.0208
BT-20	PF562271	0.04	uM	LJP6	3	F18	72	hr	1097	3188	3696	0.8625	0.8380
BT-20	PF562271	0.12	uM	LJP6	1	F17	72	hr	1097	3292	3610	0.9118	0.8953
BT-20	PF562271	0.12	uM	LJP6	2	F17	72	hr	1097	3593	3713	0.9675	0.9628
BT-20	PF562271	0.12	uM	LJP6	3	F17	72	hr	1097	3317	3696	0.8974	0.8801
BT-20	PF562271	0.37	uM	LJP6	1	F16	72	hr	1097	2946	3610	0.8159	0.7767
BT-20	PF562271	0.37	uM	LJP6	2	F16	72	hr	1097	2901	3713	0.7812	0.7380
BT-20	PF562271	0.37	uM	LJP6	3	F16	72	hr	1097	2969	3696	0.8032	0.7649
BT-20	PF562271	1.11	uM	LJP6	1	F15	72	hr	1097	2113	3610	0.5852	0.4643
BT-20	PF562271	1.11	uM	LJP6	2	F15	72	hr	1097	2320	3713	0.6247	0.5306
BT-20	PF562271	1.11	uM	LJP6	3	F15	72	hr	1097	2102	3696	0.5687	0.4492
BT-20	PF562271	3.33	uM	LJP6	1	F14	72	hr	1097	1285	3610	0.3559	0.0963
BT-20	PF562271	3.33	uM	LJP6	2	F14	72	hr	1097	1470	3713	0.3958	0.1809
BT-20	PF562271	3.33	uM	LJP6	3	F14	72	hr	1097	1323	3696	0.3579	0.1127

|<
<<
Previous
Page 303 of 535
Next
>>
>
7551 to 7575 of 13356 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)